JNJ Jan 2024 130.000 call
| Previous Close | 35.55 |
| Open | 37.50 |
| Bid | 38.05 |
| Ask | 38.45 |
| Strike | 130.00 |
| Expire Date | 2024-01-19 |
| Day's Range | 37.50 - 38.45 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 129 |
- Motley Fool
Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip Stock
While there is no perfect dividend stock, Johnson & Johnson (NYSE: JNJ) is about as great as they come. Since its founding more than 130 years ago, J&J established itself as the leading pharmaceutical company in the world. Just how big is J&J?
- Motley Fool
3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive Income
The past year reminded investors how volatile the stock markets can be. Dividend stocks can earn you steady, passive income even during tough times, and if the stocks also regularly grow their dividends, you could even build a fortune over your lifetime. If the idea of buying such a dividend stock now to earn a lifetime of passive income appeals to you, here are three stocks to check out right away.
- Motley Fool
Is Johnson & Johnson Stock Worth Buying on the Dip?
The news hasn't been great lately for healthcare giant Johnson & Johnson (NYSE: JNJ). On Jan. 24, the company reported fourth-quarter revenue of $23.7 billion, down 4.4% year over year, and earnings per share (EPS) of $1.33, down 24.9% over the previous year's quarter. Then, on Jan. 30, the Third Circuit Court of Appeals rejected the company's use of Chapter 11 bankruptcy in a shell company known as LTL Management, to avoid lawsuits over whether its talc products caused cancer.
